Streetbeat News

Products Services

NVS

Novartis has paused the enrollment of new patients in its ribociclib early breast cancer studies due to evolving regulatory guidance on nitrosamine intake limits in medications. This decision was made in alignment with health authorities.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:37 pm

LPTH

LightPath Technologies' shares surged following the announcement of its BlackDiamond-NRL infrared glass, BDNL, being used in a U.S. Department of Defense program for the first time.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:35 pm

FHTX

Foghorn Therapeutics has released new preclinical data on FHD-909, showing favorable tolerability and dose-dependent single agent activity in BRG1 mutated cancers. This development could potentially enhance the company's portfolio in cancer treatment solutions.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:34 pm

INAB

IN8bio announced the presentation of new preclinical data for its Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024, highlighting the platform's potential to selectively eliminate cancer cells while preserving healthy tissue.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:31 pm

MRIN

Marin Software's stock price increased following the announcement of an upgrade to its integration with Microsoft Advertising. This development is expected to enhance the company's advertising capabilities and potentially improve its financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:29 pm

MRIN

Marin Software has announced enhancements to its integration with Microsoft Advertising, aiming to improve advertising efficiency and outcomes for its users. This upgrade is expected to enhance the functionality and performance of Marin Software's platform by leveraging Microsoft Advertising's advanced features.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:21 pm

PRCH

Porch Group announced enhancements to its inspection products and corresponding price increases. These changes aim to improve service quality and financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:06 pm

LPTH

LightPath Technologies has announced the first incorporation of its Black Diamond (BDNL) materials within a U.S. Department of Defense (DoD) program. This new airborne system, designed to utilize LightPath's innovative materials, marks a significant milestone for the company in its defense sector engagements.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:04 pm

MURA

Mural Oncology presented preclinical data for its IL-18 and IL-12 programs at the 2024 American Association For Cancer Research Annual Meeting, indicating progress in their development. The company expects to nominate candidates for each program later this year. The data showed that their IL-18 variant, with enhanced half-life and resistance, demonstrated durable immunological effects. Additionally, their engineered IL-12 approach aims to reduce toxicity while maintaining efficacy.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 8:01 pm

PHG

The FDA has issued a consent decree on Philips, restricting the production and sale of new CPAP and BiPAP machines at several Philips Respironics facilities in the US until certain requirements are met. However, Philips Respironics is allowed to continue manufacturing and distributing some devices deemed 'medically necessary,' as specified in the decree.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 7:54 pm